Stock analysis, AI verdict, fundamentals & technical signals
Rating: HOLD
Price: $51.31 Analyst target: $63.00 Upside: 22.78%
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat blood disorders, cancer, and rare immune diseases. The company is headquartered in South San Francisco, California.
See the full interactive analysis & chart →Informational only — not investment advice.